Next Biosciences

• PGT-A — preimplantation genetic testing for aneuploidy, screening embryos for an abnormal number of chromosomes so clinics can select healthy embryos for transfer; used to improve pregnancy success rates and reduce miscarriage risk, particularly for recurrent implantation failure and severe male-factor infertility
• PGT-M — testing embryos for a known familial single-gene condition (e.g. cystic fibrosis), with a custom test designed for each family’s unique mutation and a compulsory PGT-M-specific genetic counselling session
• PGT-SR — testing embryos for structural chromosome rearrangements

Endometrial health & receptivity testing

• ERA, EMMA and ALICE — tests that determine the optimal time and environment for embryo implantation, particularly valuable for recurrent implantation failure or recurrent pregnancy loss during IVF

Pregnancy-loss & prenatal genetics

• POCScreen — genetic analysis of products of conception (miscarriage tissue testing), directly relevant for couples investigating recurrent pregnancy loss
• TriScreen NIPT — non-invasive prenatal testing assessing the risk of fetal chromosomal abnormalities in early pregnancy
• MiniMi — their additional genetics product alongside POCScreen and TriScreen

Support & adjacent services

• Genetic counselling — they have an in-house genetic counsellor, with pre-test counselling advised for PGT
• Netcells — umbilical cord blood and cord tissue stem cell banking at birth, AABB-accredited (the first cord blood bank in Africa with that accreditation), in both private and community banking options — the natural “after the fertility journey succeeds” service
• Lifestyle/health genetics (3X4 genetic testing — the product in the ad link you sent — plus PharmaGene and Viome), which are wellness rather than fertility services